The Office of Health Economics is delighted to host the Health Economists’ Study Group Summer Meeting, which will run from 30th June – 2nd July 2025. Founded in 1972, the Health Economists’ Study ...

Today marks Rare Disease Day 2025. This time last year we published an Article entitled “Why do we care about rare?”, summarising the origins of rare disease day, the fundamental ambition – to strive ...

BIA's intended use is for budget planning and evaluating potential financial impacts, but it in practice is also used in decision making, to determine HTA routing, and for commercial negotiations.

Meindert is a highly respected expert in the field of Health Technology Assessment (HTA) with more than 25 years’ experience in the field. Before starting as an independent advisor, Meindert was ...

Professor John Cairns is a Professor of Health Economics at the London School of Hygiene and tropical Medicine.

Chris is an expert in economic evaluation. His research focuses on significant methodological and policy challenges relating to the value of interventions and programmes for health. At OHE, Chris’s ...

Siva is chief analyst in the policy team, leading on projects covering NHS funding, finances, productivity and performance. Before joining the Fund in 2017, Siva was head of analysis at NHS Providers ...

Dr. Jacoline Bouvy is the Programme Director of Medicines Evaluation at the National Institute for Health and Care Excellence (NICE). She is responsible for the delivery of medicines guidance produced ...

Alastair Fischer Ph.D. has had a long career in statistics, economics and public health. He has a BSc from the University of Adelaide majoring in Pure Mathematica and Statistics, a BEc from the ...